Literature DB >> 4984254

The use of blood groups in the study of populations.

A E Mourant.   

Abstract

Mesh:

Substances:

Year:  1970        PMID: 4984254     DOI: 10.1111/j.1749-6632.1970.tb55986.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  8 in total

Review 1.  Clinical cancer genomic profiling.

Authors:  Debyani Chakravarty; David B Solit
Journal:  Nat Rev Genet       Date:  2021-03-24       Impact factor: 53.242

2.  Immune tumor board: integral part in the multidisciplinary management of cancer patients treated with cancer immunotherapy.

Authors:  Heinz Läubli; Stefan Dirnhofer; Alfred Zippelius
Journal:  Virchows Arch       Date:  2018-08-25       Impact factor: 4.064

Review 3.  Immunosuppressive circuits in tumor microenvironment and their influence on cancer treatment efficacy.

Authors:  Alessandra Tuccitto; Eriomina Shahaj; Elisabetta Vergani; Simona Ferro; Veronica Huber; Monica Rodolfo; Chiara Castelli; Licia Rivoltini; Viviana Vallacchi
Journal:  Virchows Arch       Date:  2018-10-29       Impact factor: 4.064

4.  Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancer.

Authors:  Kroopa Joshi; Marc Robert de Massy; Mazlina Ismail; James L Reading; Imran Uddin; Annemarie Woolston; Emine Hatipoglu; Theres Oakes; Rachel Rosenthal; Thomas Peacock; Tahel Ronel; Mahdad Noursadeghi; Virginia Turati; Andrew J S Furness; Andrew Georgiou; Yien Ning Sophia Wong; Assma Ben Aissa; Mariana Werner Sunderland; Mariam Jamal-Hanjani; Selvaraju Veeriah; Nicolai J Birkbak; Gareth A Wilson; Crispin T Hiley; Ehsan Ghorani; José Afonso Guerra-Assunção; Javier Herrero; Tariq Enver; Sine R Hadrup; Allan Hackshaw; Karl S Peggs; Nicholas McGranahan; Charles Swanton; Sergio A Quezada; Benny Chain
Journal:  Nat Med       Date:  2019-10-07       Impact factor: 53.440

Review 5.  Uveal melanoma.

Authors:  Martine J Jager; Carol L Shields; Colleen M Cebulla; Mohamed H Abdel-Rahman; Hans E Grossniklaus; Marc-Henri Stern; Richard D Carvajal; Rubens N Belfort; Renbing Jia; Jerry A Shields; Bertil E Damato
Journal:  Nat Rev Dis Primers       Date:  2020-04-09       Impact factor: 52.329

Review 6.  Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC.

Authors:  Mengke Niu; Ming Yi; Ning Li; Suxia Luo; Kongming Wu
Journal:  Exp Hematol Oncol       Date:  2021-03-02

Review 7.  Combination therapies utilizing neoepitope-targeted vaccines.

Authors:  Karin L Lee; Jeffrey Schlom; Duane H Hamilton
Journal:  Cancer Immunol Immunother       Date:  2020-10-08       Impact factor: 6.968

8.  APOBEC3B-mediated corruption of the tumor cell immunopeptidome induces heteroclitic neoepitopes for cancer immunotherapy.

Authors:  Christopher B Driscoll; Matthew R Schuelke; Timothy Kottke; Jill M Thompson; Phonphimon Wongthida; Jason M Tonne; Amanda L Huff; Amber Miller; Kevin G Shim; Amy Molan; Cynthia Wetmore; Peter Selby; Adel Samson; Kevin Harrington; Hardev Pandha; Alan Melcher; Jose S Pulido; Reuben Harris; Laura Evgin; Richard G Vile
Journal:  Nat Commun       Date:  2020-02-07       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.